Under RFK Jr., COVID shots will only be available to people 65+, high-risk groups

Q: How long will it take to read this news story?

The story "Under RFK Jr., COVID shots will only be available to people 65+, high-risk groups" has 132 words across 54 sentences, which will take approximately 1 - 2 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Under RFK Jr., COVID shots will only be available to people 65+, high-risk groups" was covered 19 hours ago by Ars Technica, a news publisher based in United States.

Q: How trustworthy is 'Ars Technica' news outlet?

Ars Technica is a fully independent (privately-owned) news outlet established in 1998 that covers mostly technology news. The outlet is headquartered in United States and publishes an average of 14 news stories per day. It's most recent story was published 11 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Negative, indicating that people regard this as "bad news".

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #28881971</li><li>URL: https://forold.beamstart.com/news/under-rfk-jr-covid-shots-17477737934004</li></ul>

Ars Technica 19h ago

Under RFK Jr., COVID shots will only be available to people 65+, high-risk groups - Ars Technica

Quick Summary:

The article lays out a new framework for approving seasonal COVID-19 vaccines, as well as a rationale for the change—which was made without input from independent advisory committees for the Food and Drug Administration and the Centers for Disease Control and Prevention.

The move was laid out in a commentary article published today in the New England Journal of Medicine, written by Trump administration FDA Commissioner Martin Makary and the agency's new top vaccine regulator, Vinay Prasad.

Under the control of anti-vaccine advocate Robert F.Kennedy Jr., the Food and Drug Administration is unilaterally terminating universal access to seasonal COVID-19 vaccines; instead, only people who are age 65 years and older and people with underlying conditions that put them at risk of severe COVID-19 will have access to seasonal boosters moving forward.